Genzyme's Genetic Testing Business Attracts $925 Million From LabCorp
This article was originally published in The Gray Sheet
Executive Summary
Genzyme's marginally profitable genetic testing service business is being sold to Laboratory Corporation of America for $925 million, the firms announced Sept. 13